We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.80 | 3.60 | 4.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 3.19M | -6.49M | -0.0122 | -3.11 | 20.27M |
Date | Subject | Author | Discuss |
---|---|---|---|
17/7/2024 12:56 | Erinvale, Do you think the soon (2025+) to be launched 'Launcher' a Fungicide seed treatment product by Corteva has an Eden component? | supersonico | |
17/7/2024 12:30 | 'Appointment of new Global Marketing Lead"! More new office chairs. What a shambles. | erinvale1 | |
17/7/2024 11:58 | STFU. FOAD. | neutralpov | |
17/7/2024 10:31 | A 2016 statistic to keep remembering; According to Redag, the crop protection industry normally spends $250 million over a 9-year period testing up to 140,000 candidate compounds in order to bring a single new product to market. | supersonico | |
17/7/2024 07:57 | looks like they are building a great team and looking forward to more sales and profit. | monet | |
17/7/2024 07:40 | That looks a great appointment. | kittybiscuits | |
17/7/2024 06:40 | Appointment of Global Product and Marketing Lead | supersonico | |
16/7/2024 08:51 | Added a few | alchemy | |
15/7/2024 15:12 | POV you've not taken your medication again | monet | |
15/7/2024 12:23 | So the products and geographies we have now point to great value - cash generation and profit. Let alone what's coming ? | alchemy | |
15/7/2024 11:32 | Investing, Yes it is a remarkable stat ..but it's what it says about the revenue the winning compound/s must return to pay for that investment which is also worth considering and probably is what impresses Syngenta/ Corteva and Sipcam etal PHD's and accountants in equal measure also. | supersonico | |
15/7/2024 11:10 | Super, What a stat that is. With a successful seed treatment and insecticide being brought to market, back-to-back, some industry players might be wondering how the hell Eden can do that so successfully and for relatively speaking, so little cost. | investingisatrickygame | |
15/7/2024 10:49 | A 2016 statistic worth remembering; According to Redag, the crop protection industry normally spends $250 million over a 9-year period testing up to 140,000 candidate compounds in order to bring a single new product to market. | supersonico | |
15/7/2024 01:22 | You ferkwits are gonna really really lurv prison and those nights of passion with Sambo. | neutralpov | |
14/7/2024 21:43 | On Linked in is the Sipcam Agro announcement regarding their new products and 'more exciting news' to come in late July. Ps.England got what they deserved (zero). | money never sleeps | |
14/7/2024 11:16 | Imaginary AGM Q & A Please elaborate on the current working relationship between Corteva and Eden and if the anticipated launch of 'Launcher' by Corteva has an Eden component ? Eden are currently working on more products that fall under NDA and will announce inthecoming details of any collaboration in due course. | supersonico | |
14/7/2024 09:38 | Redag Crop boasts a highly experienced and skilled management team whose previous roles including senior positions at Syngenta and Dow across both research and commercial areas. | supersonico | |
12/7/2024 19:29 | Expecting RNS v.soon :-) | kittybiscuits | |
12/7/2024 14:57 | ravenna23 12 Jul '24 - 15:05 - 17997 NPOV It has been said before by people much smarter than myself. There is a sucker born every minute. The huge denial exhibited by long term holders is no longer risible, it is sad. The recent cap raise was plain wrong. Individuals buying AIM funds were putting their money into a pit. =============== Excellent (I am one of those people, but leave that aside). Then you had to spoil it by asking pointedly -- > When will Eden sell anything? But EDEN has been selling for three decades!! Dreams. To fools, suckers, mugs, losers. On the whole successfully, too. I would have done much better at it, but then I am not a crook, and have more than enough already. Carry on. It is very amusing laughing at them but Tricky needs porridge badly, and his behind the nocturnal (if not also crepuscular) attentions of Sambo.... Know what I mean? :D | neutralpov | |
12/7/2024 14:50 | ravenna23 12 Jul '24 - 14:49 - 17995 KITTY BISCUITS I made a 70% return on my investment in Eden. I got out when I realised that the company is no more than a lucrative pension fund for the directors. What is your current return on investment with Eden. I wager it is nothing to boast about. ravenna23 12 Jul '24 - 14:58 - 17996 TIMBO_SLICE I was a holder but exited when I realised this is a Board lifestyle company. Takes your money. Delivers nothing. The recent CR was a huge AIM pump designed to deprive Tim nice but dim from his capital. I am astounded that after all these years of capital loss you are accusing me of being bitter when I am one of the 1% who has made money on Eden. Obviously I have excluded the board from this statistic as they raise money from punters, then award themselves options at a 30% discount. When will you admit that you might have made a mistake? ================ GOLD STAR POSTS! The two are the same person, though. If when a child it had been given a hard thrashing, hard enough to permanently dislodge its milk teeth, maybe its family might have suffered less. A lousy stupid braggart for whom no fate would be too cruel. | neutralpov | |
12/7/2024 14:28 | Rav,I can not see where I accused you of being bitter, I said you do not believe in EDEN anymore. I have been transparent that I do not need to sell any shares in EDEN and that I'm here for either 10's of millions in sales or bankruptcy. Hopefully, one day, you'll feel the need to buy EDEN. | timbo_slice | |
12/7/2024 14:18 | Ravenna - There is truth in what you say. But equally, even what is the point of you following it now? How do you explain the fact that Eden raised nearly 10 million pounds only recently from a series of institutional holders and a few other retail investors. That would not be possible if it was just a lifestyle business. The point is that the Directors have done what they have done to keep the business afloat during some very long and tough times and I do think any investor who had hoped for a return sooner probably did not fully appreciate the sheer length of the gestation period. I don't make any comment on why that was, e.g. whether it was misleading PR or their own eagerness to believe in a large short term reward was just around the corner. I sold out many years ago because I could see the profit was a very long way away. It is hardly relevant to fix on the history when the business is now seen to be growing its profits to point where it is just beginning to look like a sustainable year on year pattern of repeatable sales and the confidence grows as the territories and label extensions grow along with the mix of products which are only going to get better, especially when Ecovelex sales begin, and that is, before the insecticide. And before any deals with the sustaine microcencapsulation which will only happen sometime in the next phase of the business given the recent EU regulatory decision to ban plastic microenapsulation. I am only looking forward from the business we see today and whilst risks remain the share price is going nowhere for now only because of the history. There is no hope value in the price and that makes a potentially exciting investment proposition. TRT (Transense) is a company which is now in the same moment and I think it just gives investors a better potential reward for where the business is today than maybe if none of this history had ever happened. | money never sleeps | |
12/7/2024 14:16 | Synthetic Chemist – Formulation development Eden Research plc · Milton, England, United Kingdom (On-site) As a Synthetic Chemist in the Formulation team, you will be responsible for supporting the successful delivery of key projects within the company. The role requires working independently and having well-organized, detail-oriented, and excellent problem-solving skills. Job Duties: · Developing encapsulation systems for crop protection products. · Synthesising and characterising active-loaded formulations. · Development of crop protection formulations following safe-by-design protocols. · Assessing physicochemical and active control release profiles. · Collaborating closely with teams to develop and optimise scalable synthetic routes that are amenable to the preparation of crop protection products required to support manufacturing process development. Knowledge, experience & capabilities: · MSc Degree in Chemistry, or other related fields. · 2+ years of experience in an industrial synthetic chemistry lab environment. · Proven experience as a Synthetic Chemist or in a relevant position. · Proven experience in chemical cell surface modification. · Physical and chemical characterisation techniques of encapsulation systems and final formulations. · Development, production, and characterisation of encapsulation systems using biodegradable/sustai · An understanding of Agrochemical formulation and CIPAC methods. | supersonico |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions